2.4.0.80012 - Disclosure - E. CAPITAL TRANSACTIONStruefalsefalse1false falsefalseFrom2012-11-01to2013-07-31http://www.sec.gov/CIK0001304161duration2012-11-01T00:00:002013-07-31T00:00:001true 1PBSV_NotesToFinancialStatementsAbstractPBSV_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Notes to Financial Statements2false 2PBSV_CapitalTransactionsTextBlockPBSV_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">On January 23, 2013, the Company entered into an agreement with an investor relations firm to assist in the Company&#146;s shareholder communication efforts. For these services, in addition to a monthly fee of $10,000, the Company agreed to issue to the investor relations firm a total of 150,000 shares during the one year term of the agreement (75,000, 37,500 and 37,500 shares in January 2013, July 2013 and January 2014, respectively). On January 23, 2013 and July 23, 2013, the Company issued 75,000 and 37,500 shares, respectively, to the investor relations firm pursuant to the agreement.</font></p>falsefalsefalsenonnum:textBlockItemTypenaNo authoritative reference available.No definition available.false0E. CAPITAL TRANSACTIONSfalseE. CAPITAL TRANSACTIONSUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://pharmabioserv.com/role/E.CapitalTransactions12